Vistagen Therapeutics Inc.

Vistagen Therapeutics Inc is a biotechnology firm. The company is in its clinical stage and engaged in developing and commercializing product candidates for patients with diseases and disorders involving the central nervous system. Vistagen’s pipeline includes six product candidates, including five clinical-stage investigational agents belonging to a new class of drugs known as pherines. Its portfolio includes PH94B, a novel neuroactive nasal spray with therapeutic potential in a wide range of indications involving anxiety or phobia. PH10, an odorless, fast-acting synthetic neurosteroid for neuropsychiatric indications involving depression.

Address: 343 Allerton Avenue,South San Francisco South San Francisco South San Francisco CA 94080 US
Phone: +1 650 577-3600
Email: [email protected]

In The Press

Vistagen Therapeutics Inc. News